All CTMSS News

Effective November 18, 2023, Magellan has issued an updated policy regarding the coverage of TMS. The changes include: Reduction of failed medication trials from 4 to 2 from different classes Elimination of the 3 month waiting period between sessions.  To review the...

Photo: Michelle Cochran, MD, DLFAPA, FCTMSS at the 2023 APA Conference in San Francisco, CA. As the CTMSS ACROSS rep for the APA Assembly, I attended the APA meeting in San Francisco this year. As part of my participation as the representative between the CTMSS and...

The Clinical TMS Society recommends the following coverage for Transcranial Magnetic Stimulation for Smoking Cessation COVERAGE INDICATIONS, LIMITATIONS, AND/OR MEDICAL NECESSITY Introduction: Transcranial Magnetic Stimulation (TMS) is a non-invasive treatment that...

Article by Jordan Galerkin The Clinical TMS Society’s 11th Annual Meeting took place May 4-6, 2023, in Colorado Springs. This is the first time the Annual Meeting has been held in Colorado, thanks to the efforts of the Annual Meeting Committee and its chairman at the...

The Clinical TMS Society has elected the members who will serve as the 2023-2024 Officers and Board of Directors: President, Rebecca Allen, MD, MPH VP-President-Elect, Martha Koo, MD, DFAPA, FCTMSS Secretary, Sam Huber, MD, MS Treasurer, Debbie Stultz, MD, FCTMSS...

Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT), a novel approach to providing Transcranial Magnetic Stimulation (TMS) for treatment resistant depression (TRD), has generated considerable interest in the academic community and in the popular media....

Dr. Randy Pardell became involved in TMS and the world of psychology long before he was the president of the Clinical TMS Society. He grew up in northern New Jersey with a dentist for a father and a psychologist for a mother. When he was young, his mother had gone...

Dr. Mohamed Abdelghani is a prominent fellow and the current president of the Clinical TMS Society. He emigrated from Egypt to the United Kingdom seventeen years ago and has been making great strides in the field of TMS and public health in London ever since. Although...

The Clinical TMS Society recommends the following coverage for Transcranial Magnetic Stimulation for Major Depressive Disorder COVERAGE INDICATIONS, LIMITATIONS, AND/OR MEDICAL NECESSITY Introduction: Transcranial Magnetic Stimulation (TMS) is a non-invasive treatment...